Home » Healthcare » Canada Peritoneal Dialysis Market

Canada Peritoneal Dialysis Market By Type (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)); By Product (Peritoneal Dialysis Machines, Peritoneal Dialysis Solutions, Dialysis Catheters, Others); By End-user (Hospitals, Dialysis Centers, Home Care Settings) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Canada Peritoneal Dialysis Market Size 2023	USD 319.52 million
Canada Peritoneal Dialysis Market , CAGR	5.22%
Canada Peritoneal Dialysis Market Size 2032	USD 492.33 million

Market Overview

The Canada Peritoneal Dialysis Market is expected to grow from USD 319.52 million in 2023 to USD 492.33 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.22%.

The Canada peritoneal dialysis market is driven by several factors, including the rising prevalence of chronic kidney diseases (CKD) and end-stage renal failure, which increase the demand for dialysis treatments. The growing preference for home-based dialysis options due to their convenience and cost-effectiveness is also contributing to market growth. Advancements in peritoneal dialysis technologies, such as automated systems and innovative dialysate solutions, are enhancing treatment efficiency and patient comfort, further boosting adoption rates. Additionally, increasing healthcare investments and government initiatives to improve renal care are creating favorable conditions for market expansion. Trends indicate a shift towards personalized care and patient-centered approaches, with providers focusing on improving the quality of life for dialysis patients.

The Canada peritoneal dialysis market is primarily driven by the healthcare infrastructure and demand for renal care in key provinces such as Ontario, Quebec, and British Columbia. Ontario, with its large population and advanced healthcare facilities, remains a leading region for peritoneal dialysis adoption. Quebec also plays a significant role with its strong healthcare policies supporting home-based dialysis. British Columbia is emerging as a growing hub for dialysis treatments, driven by progressive healthcare initiatives. Key players in the market include Baxter International Inc., a major provider of peritoneal dialysis solutions, alongside other significant companies such as Fresenius Medical Care, DaVita Inc., and Medtronic plc, which offer a wide range of dialysis products and services. These companies, through innovations in dialysis machines, solutions, and related products, contribute significantly to market growth by improving treatment options and patient outcomes across Canada.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Canada peritoneal dialysis market was valued at USD 319.52 million in 2023 and is projected to reach USD 492.33 million by 2032, growing at a CAGR of 5.22%.
The increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is driving demand for peritoneal dialysis solutions in Canada.
The shift towards home-based dialysis and patient preference for more comfortable treatment options are key market trends.
Technological advancements in dialysis machines and solutions, such as automated and more efficient devices, are improving patient outcomes.
The market faces challenges like limited awareness and the need for better education among healthcare providers and patients about peritoneal dialysis.
Ontario and Quebec dominate the Canadian market, with growing adoption in British Columbia and Atlantic Canada.
Key players like Baxter International, Fresenius Medical Care, and DaVita Inc. are leading innovations and driving competition in the market.

Market Drivers

Rising Prevalence of Chronic Kidney Diseases (CKD)

The increasing incidence of chronic kidney diseases (CKD) and end-stage renal failure is a key driver for the Canada peritoneal dialysis market. As the population ages and lifestyle-related conditions such as hypertension and diabetes become more prevalent, the number of individuals requiring dialysis treatments continues to rise. For instance, the Kidney Foundation of Canada reports that CKD affects approximately 4 million Canadians. This trend is expected to drive market growth as more patients seek dialysis options for managing their kidney health.

Preference for Home-Based Dialysis Solutions

Another significant driver is the growing preference for home-based dialysis solutions, particularly peritoneal dialysis. Unlike hemodialysis, which requires regular visits to healthcare facilities, peritoneal dialysis can be performed at home, offering patients greater flexibility, comfort, and control over their treatment. For instance, according to a national survey, a significant number of Canadian patients prefer home-based dialysis due to these benefits. This shift is driven by the desire for convenience and improved quality of life. Home-based dialysis also helps reduce the strain on healthcare systems and allows patients to manage their condition more independently, making it a preferred option for many.

Technological Advancements in Dialysis Systems

Advancements in peritoneal dialysis technology are further fueling market growth. The development of automated peritoneal dialysis (APD) systems and advanced dialysate solutions has significantly improved treatment efficacy and patient comfort. These innovations have reduced the manual effort required for dialysis procedures and enhanced the overall experience for patients. With better monitoring systems and increased efficiency, these technological improvements are contributing to the growing adoption of peritoneal dialysis, making it a more attractive choice for patients and healthcare providers alike.

Government Initiatives and Healthcare Investments

Government initiatives and investments in healthcare infrastructure are also driving the expansion of the peritoneal dialysis market in Canada. Efforts to improve renal care services, including funding for dialysis treatments and programs to educate patients and healthcare professionals about peritoneal dialysis, are creating a supportive environment for market growth. Additionally, the Canadian healthcare system’s focus on cost-effective treatment options has made peritoneal dialysis an increasingly viable solution, further encouraging its adoption across the country.

Market Trends

Integration of Advanced Monitoring Systems

The integration of advanced monitoring systems is another emerging trend in the Canadian peritoneal dialysis market. Innovative technologies, including remote monitoring tools, are being incorporated into peritoneal dialysis systems to track patient progress and treatment effectiveness in real-time. These systems allow healthcare providers to monitor patients’ conditions remotely, offering greater oversight and enabling timely interventions. For instance, the use of e-health devices for remote patient monitoring (RPM) in automated peritoneal dialysis (APD) treatments has been shown to enhance clinical surveillance and patient management. The use of smart devices and data analytics enhances the overall management of peritoneal dialysis, ensuring more accurate and efficient treatments while reducing the need for frequent in-person visits to healthcare facilities.

Shift Toward Personalized Patient Care

A key trend in the Canada peritoneal dialysis market is the growing focus on personalized patient care. Healthcare providers are increasingly tailoring dialysis treatments to meet the specific needs of individual patients, taking into account factors such as age, lifestyle, and comorbid conditions. This trend reflects a broader shift towards patient-centered care, where treatment plans are customized to optimize both health outcomes and patient satisfaction. Personalized care in peritoneal dialysis is leading to better adherence to treatment protocols, improved quality of life for patients, and more efficient use of healthcare resources.

Increased Adoption of Home Dialysis

There is a noticeable increase in the adoption of home dialysis, particularly peritoneal dialysis, as more patients opt for treatment options that allow them to manage their condition in the comfort of their own homes. This trend is driven by the desire for greater flexibility and the ability to maintain a higher quality of life. With healthcare systems promoting home-based care to ease the burden on hospital facilities and improve patient outcomes, peritoneal dialysis has gained traction as an effective home dialysis method, further fueling market growth.

Focus on Cost-Effective Dialysis Solutions

Cost-effectiveness is becoming a significant trend in the Canadian peritoneal dialysis market. As healthcare systems face growing financial pressures, there is an increasing emphasis on cost-effective treatment options. Peritoneal dialysis, being more affordable compared to in-center hemodialysis, aligns well with this trend. With rising healthcare costs, both public and private sectors are exploring ways to reduce expenses while maintaining high-quality patient care. This trend has made peritoneal dialysis an appealing option for both patients and healthcare providers seeking efficient, cost-conscious solutions.

Market Challenges Analysis

Limited Awareness and Education

One of the primary challenges facing the Canada peritoneal dialysis market is the limited awareness and education surrounding this treatment option. Many patients and healthcare providers are more familiar with hemodialysis, often overlooking the benefits of peritoneal dialysis. This lack of awareness leads to underutilization of peritoneal dialysis, despite its advantages in terms of convenience and patient comfort. For instance, a survey conducted by the Canadian Institute for Health Information (CIHI) found that a significant number of patients were not informed about peritoneal dialysis as a treatment option. Additionally, there is a need for improved education among healthcare professionals to ensure they are well-versed in the latest technological advancements and best practices related to peritoneal dialysis. Without adequate knowledge, there is a risk that patients may not be offered the most appropriate treatment options, hindering the potential growth of the peritoneal dialysis market in Canada.

Supply Chain and Infrastructure Constraints

Another significant challenge is the existing limitations in supply chain and infrastructure for peritoneal dialysis treatments. The availability of the necessary equipment, supplies, and medications required for effective peritoneal dialysis is critical, yet shortages and delays in the supply chain can disrupt treatment plans. Furthermore, while home-based dialysis has gained popularity, not all patients have access to the required infrastructure to support home dialysis setups, such as storage space and reliable access to consumables. Inadequate healthcare facilities and resources, particularly in rural and remote areas, can limit the widespread adoption of peritoneal dialysis, posing a barrier to market growth and access to this life-saving treatment.

Market Opportunities

Expansion of Home Dialysis Programs

One of the key opportunities in the Canada peritoneal dialysis market lies in the expansion of home dialysis programs. As healthcare systems increasingly focus on providing cost-effective, patient-centered care, home-based peritoneal dialysis presents a compelling solution. The convenience of performing dialysis at home appeals to many patients, allowing them to maintain a higher quality of life while reducing the burden on healthcare facilities. With government initiatives supporting home healthcare models, there is significant potential for growth in this segment. Additionally, advancements in remote monitoring and telemedicine provide healthcare providers with the tools to oversee patients’ conditions from a distance, further supporting the adoption of home dialysis.

Technological Innovations and Improved Patient Outcomes

Another notable opportunity is the continuous technological innovation in peritoneal dialysis systems. The development of more efficient, automated, and user-friendly peritoneal dialysis machines offers the potential to enhance patient outcomes and make treatments more accessible. Automated peritoneal dialysis (APD) systems, for example, reduce the manual effort required, improving convenience and compliance for patients. Additionally, the introduction of advanced dialysate solutions and smart monitoring technologies enables more precise and effective treatment. These innovations can drive market growth by increasing the appeal of peritoneal dialysis to both patients and healthcare providers, particularly as new technologies improve the ease of use, efficiency, and overall treatment experience.

Market Segmentation Analysis:

By Type:

The Canada peritoneal dialysis market is primarily segmented into two types: Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). CAPD, a manual form of peritoneal dialysis, continues to dominate the market due to its simplicity and minimal equipment requirements, making it suitable for patients who prefer to manage their treatment at home. However, Automated Peritoneal Dialysis (APD) is experiencing rapid growth due to its convenience and efficiency. APD involves the use of a machine to perform the dialysis process overnight while the patient sleeps, allowing for greater comfort and reduced treatment time. As healthcare technology improves, APD is expected to see increased adoption due to its ability to provide more consistent and precise dialysis, offering patients a better quality of life and higher treatment adherence. Both types play a crucial role in offering flexible dialysis solutions, catering to different patient needs.

By Product:

The Canada peritoneal dialysis market is further segmented based on products, including peritoneal dialysis machines, peritoneal dialysis solutions, dialysis catheters, and other related products. Peritoneal dialysis machines are critical in automated dialysis processes, and their advanced features, such as improved monitoring capabilities, are driving their demand. Peritoneal dialysis solutions, which contain the necessary fluids for the dialysis process, are essential for maintaining the balance of electrolytes and waste removal. The demand for high-quality, reliable dialysis catheters remains strong, as they facilitate the dialysis process by connecting the patient to the dialysis machine. Other products in this segment include accessories and consumables that support dialysis procedures. As the preference for home dialysis grows, the market for related products is expanding, creating significant opportunities for manufacturers to innovate and meet the increasing demand for high-quality, efficient dialysis solutions.

Segments:

Based on Type:

Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)

Based on Product:

Peritoneal Dialysis Machines
Peritoneal Dialysis Solutions
Dialysis Catheters
Others

Based on End-user:

Hospitals
Dialysis Centers
Home Care Settings

Based on the Geography:

Ontario
Quebec
Western Canada
British Columbia
Atlantic Canada

Regional Analysis

Ontario

Ontario, the most populous province in Canada, holds the largest share of the peritoneal dialysis market due to its advanced healthcare infrastructure, high patient population, and robust government support for healthcare services. Ontario leads the market with a share of approximately 38%. The province is home to major cities such as Toronto and Ottawa, which have extensive medical facilities and specialized renal care units. The increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in Ontario is further driving demand for peritoneal dialysis. Additionally, government programs and policies that promote home-based dialysis solutions are contributing to the region’s market growth. With increasing awareness and availability of innovative dialysis technologies, Ontario is poised for continued growth in peritoneal dialysis treatments.

Quebec

Quebec, with its significant healthcare system and growing elderly population, is the second-largest contributor to the peritoneal dialysis market in Canada, accounting for approximately 28% of the market share. The province has made strides in improving renal care, with specialized centers offering both traditional and home-based dialysis treatments. Quebec’s healthcare policies, which focus on improving patient outcomes and expanding access to treatment options, are key factors driving the adoption of peritoneal dialysis. Furthermore, the province’s strong emphasis on patient education and support services has resulted in increasing patient preference for peritoneal dialysis, enhancing its market growth.

Western Canada and British Columbia

Western Canada, particularly British Columbia, represents a growing segment of the peritoneal dialysis market, contributing to around 16% of the total market share. British Columbia, with its progressive healthcare systems and emphasis on patient-centered care, has seen an uptick in home dialysis adoption. The province is actively promoting the benefits of home-based treatments like peritoneal dialysis through initiatives that increase accessibility and reduce treatment costs. Vancouver, as a key healthcare hub, has witnessed an increase in the availability of advanced peritoneal dialysis machines and solutions. The rising awareness of chronic kidney disease and the province’s push for more efficient, cost-effective treatment methods are expected to continue driving market growth in this region.

Atlantic Canada

Atlantic Canada, encompassing the provinces of Newfoundland and Labrador, Nova Scotia, New Brunswick, and Prince Edward Island, accounts for about 18% of the Canada peritoneal dialysis market. While the market share in this region is smaller compared to Ontario and Quebec, it is steadily growing due to increasing healthcare investments and a rising patient base. The healthcare infrastructure in Atlantic Canada is improving, with more emphasis on home dialysis options and community-based care models. As regional healthcare providers invest in peritoneal dialysis technologies and patient education, demand is expected to increase, contributing to the market’s overall expansion. The region’s smaller but growing elderly population and the rising prevalence of CKD provide significant opportunities for market penetration.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Baxter International Inc.
Fresenius Medical Care
DaVita Inc.
NxStage Medical, Inc.
Medtronic plc
Dialysis Clinic, Inc.
Outset Medical, Inc.
American Renal Associates
Quanta Dialysis Technologies
Biomedica Diagnostics Inc.

Competitive Analysis

The Canada peritoneal dialysis market is highly competitive, with several leading players focusing on innovation and expansion to capture a larger market share. Key players in the market include Baxter International Inc., Fresenius Medical Care, DaVita Inc., NxStage Medical, Inc., Medtronic plc, Dialysis Clinic, Inc., Outset Medical, Inc., American Renal Associates, Quanta Dialysis Technologies, and Biomedica Diagnostics Inc. Leading players in the market focus on developing advanced technologies such as automated peritoneal dialysis systems, which enhance patient comfort and improve treatment efficiency. Companies are also investing in research and development to improve the quality of peritoneal dialysis solutions, dialysis machines, and catheters, with the aim of providing more effective and user-friendly products. Competitive strategies include expanding product portfolios, forming strategic partnerships, and increasing market presence through distribution networks. Many companies are focusing on the growing trend of home dialysis by introducing products that enable easier management of treatment at home. For example, the introduction of home dialysis programs by various healthcare providers has significantly increased the accessibility of peritoneal dialysis. Additionally, the shift towards personalized care models and greater patient education is influencing competitive dynamics. The ongoing innovation and efforts to improve patient outcomes are crucial factors driving competition in the market. The key players are focused on making dialysis more accessible, cost-effective, and comfortable, which will likely continue to shape the competitive landscape in Canada’s peritoneal dialysis market.

Recent Developments

In August 2024, Baxter International Inc (US) and Carlyle (US) signed a definitive agreement under which Carlyle will acquire Baxter’s Kidney Care segment. The segment will be named Vantive, with the aim of creating a standalone kidney care company.

In April 2023, Medtronic plc (Ireland) and DaVita Inc (US) launched Mozarc Medical—an independent new company that aims to reshape kidney health and drive patient-centered technology solutions.

In August 2022, Fresenius Medical Care AG (Germany) acquired InterWell Health (US), a physician organization that drives innovation in the kidney care space in the US, and Cricket Health. Inc (US), provider of value-based kidney care with patient engagement and data platform.

Market Concentration & Characteristics

The Canada peritoneal dialysis market exhibits a moderate level of concentration, with several major players dominating the landscape while leaving room for smaller and emerging companies to compete. The market is characterized by the presence of both global leaders and regional players that focus on offering innovative products to meet the growing demand for home dialysis. Major companies dominate with extensive product portfolios, including dialysis machines, solutions, and related accessories, while newer entrants aim to provide specialized and cost-effective solutions that cater to niche patient needs. The market is also marked by technological advancements, with a strong emphasis on developing automated systems that enhance the convenience and comfort of home dialysis treatments. Companies are increasingly focusing on patient-centric products, driven by the shift towards home-based treatments and the growing preference for self-management options. This trend is reshaping the competitive dynamics, as established players continuously improve their offerings, while new entrants strive to differentiate themselves through innovative solutions. The market’s competitive characteristics also include strategic collaborations, acquisitions, and expansions, which are common as companies aim to strengthen their market position and broaden their reach. Overall, the market is evolving towards a more patient-focused, technologically advanced, and accessible landscape.

Report Coverage

The research report offers an in-depth analysis based on Type, Product, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Canada peritoneal dialysis market is expected to grow significantly, driven by an increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD).
Technological advancements in dialysis machines and solutions will enhance treatment outcomes and improve patient comfort.
The shift towards home-based dialysis will continue to drive market growth as more patients opt for self-management options.
Automated peritoneal dialysis systems will see higher adoption due to their ability to reduce patient burden and improve convenience.
The Canadian government’s focus on improving healthcare accessibility will promote the growth of home dialysis therapies.
Increased awareness about peritoneal dialysis will encourage more patients and healthcare providers to choose this treatment option.
Strategic collaborations between healthcare providers and dialysis solution manufacturers will expand the availability of advanced products.
The market will witness a rise in patient education programs, making dialysis treatments more accessible and manageable for patients.
Rising investments in research and development will lead to more innovative and cost-effective peritoneal dialysis solutions.
As the aging population grows, the demand for dialysis treatments, including peritoneal dialysis, is expected to increase, expanding market opportunities.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Peritoneal Dialysis Market Snapshot 21

2.1.1. CANADA Peritoneal Dialysis Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : PERITONEAL DIALYSIS MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Rising prevalence of chronic kidney diseases (CKD) 25

4.2.2. Growing adoption of home dialysis treatments 26

4.3. Market Restraints 27

4.3.1. High cost of peritoneal dialysis equipment and treatments 27

4.4. Market Opportunities 28

4.4.1. Technological advancements in automated dialysis systems 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by CANADA 31

5.1.1. CANADA Peritoneal Dialysis Market Import Volume/Revenue, By CANADA, 2018 – 2023 31

5.2. Export Analysis by CANADA 32

5.2.1. CANADA Peritoneal Dialysis Market Export Volume/Revenue, By CANADA, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by CANADA 33

6.1.1. CANADA Peritoneal Dialysis Market Demand Volume/Revenue, By CANADA, 2018 – 2023 33

6.2. Supply Analysis by CANADA 34

6.2.1. CANADA Peritoneal Dialysis Market Supply Volume/Revenue, By CANADA, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by CANADA 35

7.1.1. CANADA Peritoneal Dialysis Market Production Volume/Revenue, By CANADA, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. CANADA Peritoneal Dialysis Market Price, By Type, 2018 – 2023 36

8.1.2. CANADA Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. CANADA Peritoneal Dialysis Market: Company Market Share, by Volume, 2023 40

11.2.2. CANADA Peritoneal Dialysis Market: Company Market Share, by Revenue, 2023 41

11.2.3. CANADA Peritoneal Dialysis Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. CANADA Peritoneal Dialysis Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. CANADA Peritoneal Dialysis Market Company Volume Market Share, 2023 43

11.4. CANADA Peritoneal Dialysis Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

CANADA Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : PERITONEAL DIALYSIS MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Peritoneal Dialysis Market Overview, by Type Segment 49

13.1.1. Peritoneal Dialysis Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Peritoneal Dialysis Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Continuous Ambulatory Peritoneal Dialysis (CAPD) 53

13.3. Automated Peritoneal Dialysis (APD) 54

CHAPTER NO. 14 : PERITONEAL DIALYSIS MARKET – BY PRODUCT SEGMENT ANALYSIS 55

14.1. Peritoneal Dialysis Market Overview, by Product Segment 55

14.1.1. Peritoneal Dialysis Market Revenue Share, By Product, 2023 & 2032 56

14.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By Product 57

14.1.3. Incremental Revenue Growth Opportunity, by Product, 2024 – 2032 57

14.1.4. Peritoneal Dialysis Market Revenue, By Product, 2018, 2023, 2027 & 2032 58

14.2. Peritoneal Dialysis Machines 59

14.3. Peritoneal Dialysis Solutions 60

14.4. Dialysis Catheters 61

14.5. Others 62

CHAPTER NO. 15 : PERITONEAL DIALYSIS MARKET – BY END-USER SEGMENT ANALYSIS 63

15.1. Peritoneal Dialysis Market Overview, by End-user Segment 63

15.1.1. Peritoneal Dialysis Market Revenue Share, By End-user, 2023 & 2032 64

15.1.2. Peritoneal Dialysis Market Attractiveness Analysis, By End-user 65

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 65

15.1.4. Peritoneal Dialysis Market Revenue, By End-user, 2018, 2023, 2027 & 2032 66

15.2. Hospitals 67

15.3. Dialysis Centers 68

15.4. Home Care Settings 69

CHAPTER NO. 16 : PERITONEAL DIALYSIS MARKET – CANADA ANALYSIS 70

16.1. Type 70

16.1.1. CANADA Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 (USD Million) 70

16.2. CANADA Peritoneal Dialysis Market Revenue, By Type, 2024 – 2032 (USD Million) 70

16.3. Product 71

16.3.1. CANADA Peritoneal Dialysis Market Revenue, By Product, 2018 – 2023 (USD Million) 71

16.3.2. CANADA Peritoneal Dialysis Market Revenue, By Product, 2024 – 2032 (USD Million) 71

16.4. End-user 72

16.4.1. CANADA Peritoneal Dialysis Market Revenue, By End-user, 2018 – 2023 (USD Million) 72

16.4.2. CANADA Peritoneal Dialysis Market Revenue, By End-user, 2024 – 2032 (USD Million) 72

CHAPTER NO. 17 : COMPANY PROFILES 73

17.1. Baxter International Inc. 73

17.1.1. Company Overview 73

17.1.2. Product Portfolio 73

17.1.3. Swot Analysis 73

17.1.4. Business Strategy 74

17.1.5. Financial Overview 74

17.2. Fresenius Medical Care 75

17.3. DaVita Inc. 75

17.4. NxStage Medical, Inc. 75

17.5. Medtronic plc 75

17.6. Dialysis Clinic, Inc. 75

17.7. Outset Medical, Inc. 75

17.8. American Renal Associates 75

17.9. Quanta Dialysis Technologies 75

17.10. Biomedica Diagnostics Inc. 75

List of Figures

FIG NO. 1. CANADA Peritoneal Dialysis Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for CANADA Peritoneal Dialysis Market 29

FIG NO. 3. CANADA Peritoneal Dialysis Market Import Volume/Revenue, By CANADA, 2018 – 2023 31

FIG NO. 4. CANADA Peritoneal Dialysis Market Export Volume/Revenue, By CANADA, 2018 – 2023 32

FIG NO. 5. CANADA Peritoneal Dialysis Market Demand Volume/Revenue, By CANADA, 2018 – 2023 33

FIG NO. 6. CANADA Peritoneal Dialysis Market Supply Volume/Revenue, By CANADA, 2018 – 2023 34

FIG NO. 7. CANADA Peritoneal Dialysis Market Production Volume/Revenue, By CANADA, 2018 – 2023 35

FIG NO. 8. CANADA Peritoneal Dialysis Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for CANADA Peritoneal Dialysis Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Peritoneal Dialysis Market – Company Volume Market Share, 2023 43

FIG NO. 18. Peritoneal Dialysis Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Peritoneal Dialysis Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Peritoneal Dialysis Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. CANADA Peritoneal Dialysis Market for Continuous Ambulatory Peritoneal Dialysis (CAPD), Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. CANADA Peritoneal Dialysis Market for Automated Peritoneal Dialysis (APD), Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Peritoneal Dialysis Market Revenue Share, By Product, 2023 & 2032 56

FIG NO. 26. Market Attractiveness Analysis, By Product 57

FIG NO. 27. Incremental Revenue Growth Opportunity by Product, 2024 – 2032 57

FIG NO. 28. Peritoneal Dialysis Market Revenue, By Product, 2018, 2023, 2027 & 2032 58

FIG NO. 29. CANADA Peritoneal Dialysis Market for Peritoneal Dialysis Machines, Revenue (USD Million) 2018 – 2032 59

FIG NO. 30. CANADA Peritoneal Dialysis Market for Peritoneal Dialysis Solutions, Revenue (USD Million) 2018 – 2032 60

FIG NO. 31. CANADA Peritoneal Dialysis Market for Dialysis Catheters, Revenue (USD Million) 2018 – 2032 61

FIG NO. 32. CANADA Peritoneal Dialysis Market for Others, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Peritoneal Dialysis Market Revenue Share, By End-user, 2023 & 2032 64

FIG NO. 34. Market Attractiveness Analysis, By End-user 65

FIG NO. 35. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 65

FIG NO. 36. Peritoneal Dialysis Market Revenue, By End-user, 2018, 2023, 2027 & 2032 66

FIG NO. 37. CANADA Peritoneal Dialysis Market for Hospitals, Revenue (USD Million) 2018 – 2032 67

FIG NO. 38. CANADA Peritoneal Dialysis Market for Dialysis Centers, Revenue (USD Million) 2018 – 2032 68

FIG NO. 39. CANADA Peritoneal Dialysis Market for Home Care Settings, Revenue (USD Million) 2018 – 2032 69

List of Tables

TABLE NO. 1. : CANADA Peritoneal Dialysis Market: Snapshot 21

TABLE NO. 2. : Drivers for the Peritoneal Dialysis Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Peritoneal Dialysis Market: Impact Analysis 27

TABLE NO. 4. : CANADA Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : CANADA Peritoneal Dialysis Market Revenue, By Type, 2018 – 2023 (USD Million) 70

TABLE NO. 7. : CANADA Peritoneal Dialysis Market Revenue, By Type, 2024 – 2032 (USD Million) 70

TABLE NO. 8. : CANADA Peritoneal Dialysis Market Revenue, By Product, 2018 – 2023 (USD Million) 71

TABLE NO. 9. : CANADA Peritoneal Dialysis Market Revenue, By Product, 2024 – 2032 (USD Million) 71

TABLE NO. 10. : CANADA Peritoneal Dialysis Market Revenue, By End-user, 2018 – 2023 (USD Million) 72

TABLE NO. 11. : CANADA Peritoneal Dialysis Market Revenue, By End-user, 2024 – 2032 (USD Million) 72

Frequently Asked Questions

What is the current size of the Canada Peritoneal Dialysis market?

The Canada Peritoneal Dialysis market is valued at USD 319.52 million in 2023 and is projected to grow to USD 492.33 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.22%.

What factors are driving the growth of the Canada Peritoneal Dialysis market?

The market is driven by the rising prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD), increasing preference for home-based dialysis solutions, and advancements in peritoneal dialysis technologies such as automated systems. Government initiatives and healthcare investments to improve renal care services also play a significant role in driving market growth.

What are the key segments within the Canada Peritoneal Dialysis market?

The market is segmented by type into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). It is further segmented by product into peritoneal dialysis machines, dialysis solutions, dialysis catheters, and other related products. End-user categories include hospitals, dialysis centers, and home care settings, while geographical segments include Ontario, Quebec, Western Canada, British Columbia, and Atlantic Canada.

What are some challenges faced by the Canada Peritoneal Dialysis market?

Challenges include limited awareness and education about peritoneal dialysis among both patients and healthcare providers, as well as supply chain and infrastructure constraints that affect the availability of necessary equipment and support for home-based dialysis treatments. These factors hinder the widespread adoption of peritoneal dialysis in some areas.

Who are the major players in the Canada Peritoneal Dialysis market?

Key players in the market include Baxter International Inc., Fresenius Medical Care, DaVita Inc., NxStage Medical, Inc., Medtronic plc, and Dialysis Clinic, Inc. These companies focus on developing innovative products and expanding their reach through strategic collaborations, enhancing their competitiveness in the market.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –